Dr. Zenga is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
9200 W Wisconsin Ave
Milwaukee, WI 53226Phone+1 414-805-5580Fax+1 414-805-8324
Education & Training
Washington University/B-JH/SLCH ConsortiumResidency, Otolaryngology - Head and Neck Surgery, 2012 - 2017- Washington University in St. Louis School of MedicineClass of 2012
Certifications & Licensure
WI State Medical License 2018 - 2025
MA State Medical License 2017 - 2020
MO State Medical License 2012 - 2017- American Board of Otolaryngology - Head and Neck Surgery Otolaryngology
Publications & Presentations
PubMed
- 1 citationsTumor-specific T cells in head and neck cancer have rescuable functionality and can be identified through single-cell co-culture.Joseph Zenga, Musaddiq Awan, Anne Frei, Jamie Foeckler, Rachel Kuehn
Translational Oncology. 2024-04-01 - 39 citationsState of the art: Rehabilitation of speech and swallowing after total laryngectomy.Joseph Zenga, Tessa Goldsmith, Glenn Bunting, Daniel G. Deschler
Oral Oncology. 2018-09-12 - 33 citationsTreatment Outcomes for T4 Oropharyngeal Squamous Cell CarcinomaJoseph Zenga, Michael Wilson, Douglas Adkins, Bruce H. Haughey, Dorina Kallogjeri
JAMA Otolaryngology-- Head & Neck Surgery. 2015-12-01
Journal Articles
- Evaluating Adjuvant Therapy with Chemoradiation vs Radiation Alone for Patients with HPV-Negative N2a Head and Neck CancerDavid M Neskey, Patrik Pipkorn, Joseph Zenga, Evan M Graboyes, JAMA Otolaryngology–Head & Neck Surgery
Authored Content
- Evaluating Adjuvant Therapy with Chemoradiation vs Radiation Alone for Patients with HPV-Negative N2a Head and Neck CancerAugust 2020
- Salvage of Recurrence After Surgery and Adjuvant Therapy: A Systematic Review☆☆☆February 2018
Press Mentions
Researcher Pilots New Process That Reduces the Length of Cancer Radiation TreatmentsOctober 28th, 2022- WashU ENT Has Strong Presence at Annual AAO-HNSF MeetingAugust 30th, 2022
- Notable Oral Abstracts and Late-Breaking Science to Be Presented at Otolaryngology’s Annual MeetingSeptember 30th, 2021
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
